Skip to main content
. 2023 Jul 20;14:1205984. doi: 10.3389/fimmu.2023.1205984

Figure 1.

Figure 1

Differentiation of TRM in tissue. Priming and differentiation of naïve CD8+ T cells take place in the lymph node in contact with monocytes or dendritic cells (DC3) which promote the generation of CD8+ TRM precursors. Through cytokines secretion such as IFN-γ or IL-21, CD4+ T cells help CD8+ T cells to be fully functional and influence the TRM differentiation. Primed CD8+ TRM precursor cells reach the inflamed sites where they differentiate into CD8+ TRM. Within the tissue, several cellular components regulate and maintain TRM cells: DC3 participate in positioning CD8+ TRM cells in an immune niche and promote their survival, DC infiltrating tumors, tumor cells or epithelial cells express integrin αvβ6 and αvβ8 and transform LAP-TGF-β to active TGF-β. Active TGF-β maintains tissue residence of TRM cells and initiates CD103 signaling leading to functional and cytotoxic TRM cells. CD4+ TRM cells have recently been identified and are also present in peripheral tissues and solid tumors where they secrete inflammatory cytokines such as IFN-γ, TNF-α or IL-2.